|
CA2594927A1
|
|
Hunter-killer peptides and methods of use
|
|
US2005256040A1
|
|
Artificially designed pore-forming proteins with anti-tumor effects
|
|
US2005241008A1
|
|
Transgenic mouse whose genome comprises an APP having a mutation at amino acid 664
|
|
WO2004084830A2
|
|
Method for treating alzheimer’s dementia
|
|
AU2003291635A8
|
|
Automated method for high throughput screening of nematodes
|
|
AU2003248635A1
|
|
Secretases related to alzheimer's dementia
|
|
AU2003231980A1
|
|
Identification of apoptotic peptides and methods of use thereof
|
|
AU2003213078A1
|
|
Neurogenerative or neurotrophic factors for mitigating a symptom of ischemia
|
|
WO03040332A2
|
|
Neuroglobin is up-regulated by and protects neuronsfrom hypoxic-ischemic injury
|
|
WO03029821A1
|
|
Target assisted iterative screening (tais) : a novel screening format for large molecular repertoires
|
|
US2006099713A1
|
|
Targeted-assisted iterative screening (tais):a novel screening format for large molecular repertoires
|
|
US2005244894A1
|
|
Modulators of paraptosis and related methods
|
|
CA2443160A1
|
|
Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof
|
